These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1322153)

  • 1. Clinical trials referral resource. Non-small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1992 Jul; 6(7):44, 49-50. PubMed ID: 1322153
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R
    Rays; 2004; 29(4):435-7. PubMed ID: 15852732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
    Mornex F
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials referral resource. Small-cell lung cancer.
    Cheson BD; Feigal EG; Phillips PH
    Oncology (Williston Park); 1993 Oct; 7(10):43-7. PubMed ID: 8251307
    [No Abstract]   [Full Text] [Related]  

  • 5. A retrospective study of concurrent chemoradiation using mitomycin, vinblastine and cisplatin chemotherapy for non-small cell lung cancer.
    Newman G
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):728. PubMed ID: 19628378
    [No Abstract]   [Full Text] [Related]  

  • 6. Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Perez EA; Gandara DR
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):2-5. PubMed ID: 8209273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of small cell lung cancer].
    Ueoka H; Ohnoshi T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
    Baumann M
    Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
    Vokes EE; Leopold KA; Herndon J; Green MR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-42-S8-45. PubMed ID: 9207317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.
    Saxman SB; Blatner GL; Cheson BD
    Oncology (Williston Park); 1999 Oct; 13(10):1384, 1387-8. PubMed ID: 10549565
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined modality treatment for non-small cell lung cancer].
    Ueoka H; Tabata M
    Nihon Rinsho; 2002 May; 60 Suppl 5():455-8. PubMed ID: 12101713
    [No Abstract]   [Full Text] [Related]  

  • 12. Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer.
    van Zandwijk N; Dalesio O
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):66-71. PubMed ID: 8052876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vinorelbine for non-small cell lung cancer].
    Seto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy.
    Bonomi P
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):101-8. PubMed ID: 8052869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. Small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Jan; 4(1):43-56. PubMed ID: 2168198
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
    Papacharalambous A; Rigatos G; Alexopoulos A; Stavrakakis J; Scartsilas C; Stavrinidis E
    J Chemother; 1989 Jul; 1(4 Suppl):1214-5. PubMed ID: 16312839
    [No Abstract]   [Full Text] [Related]  

  • 18. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Ardizzoni A; Fusco V; Gulisano M; Pronzato P; Baracco F; Capaccio A; Pastorino G; Nosenzo M; Felletti R; Fabiano F
    Cancer Treat Rep; 1987 Dec; 71(12):1311-2. PubMed ID: 2825994
    [No Abstract]   [Full Text] [Related]  

  • 19. Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?
    Dediu M
    J Clin Oncol; 2004 Apr; 22(7):1345-7; author reply 1347. PubMed ID: 15051791
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination chemotherapy of CDDP and etoposide in advanced non-small cell carcinoma of the lung].
    Kodama N; Furuse K; Kawahara M; Arai R; Yamamoto M; Tsuruta M; Kubota K; Ogawara M; Nakai R; Kawano S
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3233-7. PubMed ID: 2848457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.